267690 Provider perceptions of how HIV-related stigma might impact testing, treatment and adherence among HIV-positive Latino patients in the U.S.-Mexico border region

Monday, October 29, 2012 : 1:00 PM - 1:15 PM

Fatima A. Muñoz, MD MPH , Division of Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA
Justine Kozo, MPH , Division of Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA
Argentina Servin, MD , Division of Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA
Rosana Scolari, BA , San Ysidro Health Center, San Ysidro Health Center, San Ysidro, CA
María. Luisa Zúñiga, PhD , School of Medicine, University of California, San Diego, La Jolla, CA
Background: HIV-related stigma remains an elusive problem with demonstrated impact on care engagement. There is limited research on how HIV-related stigma affects patients, from the provider's perspective. We conducted a binational qualitative study to explore provider perceptions of how HIV-related stigma impacts their patients' care in the U.S.-Mexico border region.

Methods: We conducted semi-structured qualitative in-depth interviews with 19 HIV health care providers in Tijuana and San Diego (June/2010-January/2011). Transcripts were coded drawing upon principles of Grounded Theory.

Results: Providers from both cities mentioned that HIV-related stigma might influence patients' likelihood to get tested, engage in HIV care and adhere to HIV treatment. Primary themes were: i. self-perceived stigma – providers perceived that some patients do not readily disclose their HIV status and/or fear rejection because of their positive status; and fear being labeled as HIV positive or having AIDS due to observable physical changes. ii. Community stigma- providers suggested that rejection and isolation by family and partners may influence the patient's decision to continue treatment and may negatively influence mental health (e.g. depression). iii. Health provider and work environment stigma- providers reported patient descriptions of discrimination, isolation and rejection in the workplace and non-HIV care settings.

Conclusions: Clinicians caring for a largely binational patient population described multiple instances of patient perceived HIV-related stigma. Fear of being stigmatized at any level, may influence testing behavior and negatively affect patient's willingness to access care. Interventions are needed to reduce structural/social stigma in the work place and community.

Learning Areas:
Administer health education strategies, interventions and programs
Clinical medicine applied in public health
Implementation of health education strategies, interventions and programs
Other professions or practice related to public health
Provision of health care to the public
Social and behavioral sciences

Learning Objectives:
• Describe how HIV-related stigma affects care-seeking behaviors among people living with HIV in a binational context. •Discuss the negative impact of HIV-related stigma on HIV testing, treatment and adherence from the provider’s perspectives. •Demonstrate the complexity of the different manifestations of the stigma (e.g., personal, community and structural level) among HIV positive Latino population living in the US-Mexico border region.

Keywords: Access to Care, HIV/AIDS

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the primary author of this study and I have been working with the principal investigator in many of her projects focus on improving the health of Latino populations living with HIV/AIDS in the US-Mexico border region. Specific areas of our health research include: Complementary and Alternative Medicine use among HIV-Positive individuals living in the US-Mexico border region, HIV-related stigma and HIV-transmitting risk behaviors, including health care delivery and binational health care services utilization.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3238.0: Barriers to HIV/AIDS Care 2